Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.

Pracht M, Mogha A, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD, Lesimple T.

J Eur Acad Dermatol Venereol. 2015 Jan 26. doi: 10.1111/jdv.12910. [Epub ahead of print]

PMID:
25623140
2.

Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.

Lemée JM, Clavreul A, Aubry M, Com E, de Tayrac M, Eliat PA, Henry C, Rousseau A, Mosser J, Menei P.

J Neurooncol. 2015 Mar;122(1):53-61. doi: 10.1007/s11060-014-1695-8. Epub 2015 Jan 6.

PMID:
25559687
3.

Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.

Clavreul A, Etcheverry A, Tétaud C, Rousseau A, Avril T, Henry C, Mosser J, Menei P.

J Neurooncol. 2015 Mar;122(1):1-10. doi: 10.1007/s11060-014-1683-z. Epub 2014 Dec 13.

PMID:
25503303
4.

Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.

de Tayrac M, Roth MP, Jouanolle AM, Coppin H, le Gac G, Piperno A, Férec C, Pelucchi S, Scotet V, Bardou-Jacquet E, Ropert M, Bouvet R, Génin E, Mosser J, Deugnier Y.

J Hepatol. 2015 Mar;62(3):664-72. doi: 10.1016/j.jhep.2014.10.017. Epub 2014 Oct 18.

PMID:
25457201
5.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.

Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, Desrues B, Léna H.

Lung Cancer. 2015 Jan;87(1):80-4. doi: 10.1016/j.lungcan.2014.11.005. Epub 2014 Nov 20.

PMID:
25433984
6.

DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.

Etcheverry A, Aubry M, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.

PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.

7.

A case of a generalized lichenoid tattoo reaction.

Jacks SK, Zirwas MJ, Mosser JL.

J Clin Aesthet Dermatol. 2014 Aug;7(8):48-50.

8.

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V.

J Proteomics. 2014 Oct 14;110:7-19. doi: 10.1016/j.jprot.2014.07.022. Epub 2014 Aug 1.

PMID:
25088051
9.

Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use.

Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

PLoS One. 2014 Jan 17;9(1):e79578. doi: 10.1371/journal.pone.0079578. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e93878.

10.

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients.

Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D.

J Neurooncol. 2014 Feb;116(3):487-96. doi: 10.1007/s11060-013-1332-y. Epub 2014 Jan 14.

11.

A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms.

Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.

J Mol Diagn. 2014 Jan;16(1):45-55. doi: 10.1016/j.jmoldx.2013.07.009. Epub 2013 Oct 30.

PMID:
24183959
12.

Prognostic significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, four new markers in high-grade gliomas.

de Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.

PLoS One. 2013 Sep 11;8(9):e73332. doi: 10.1371/journal.pone.0073332. eCollection 2013.

13.

Mortality and long-term virologic outcomes in children and infants treated with lopinavir/ritonavir.

Estripeaut D, Mosser J, Doherty M, Acosta W, Shah H, Castaño E, Luciani K, Pascale JM, Bollinger RC, Page KR.

Pediatr Infect Dis J. 2013 Dec;32(12):e466-72. doi: 10.1097/INF.0b013e3182a09276.

14.

Immune genes are associated with human glioblastoma pathology and patient survival.

Vauléon E, Tony A, Hamlat A, Etcheverry A, Chiforeanu DC, Menei P, Mosser J, Quillien V, Aubry M.

BMC Med Genomics. 2012 Sep 14;5:41. doi: 10.1186/1755-8794-5-41.

15.

U.S. EPA response to the Fukushima Daiichi Nuclear Power Plant accident.

Tupin EA, Boyd MA, Mosser JE, Wieder JS.

Health Phys. 2012 May;102(5):563-9. doi: 10.1097/HP.0b013e31824cc02e.

PMID:
22469933
16.

Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.

Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chalès G, Mosser J, Loréal O, Guggenbuhl P.

Osteoporos Int. 2012 Oct;23(10):2435-45. doi: 10.1007/s00198-011-1871-z. Epub 2012 Jan 12.

PMID:
22237814
17.

Isolation of a new cell population in the glioblastoma microenvironment.

Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P.

J Neurooncol. 2012 Feb;106(3):493-504. doi: 10.1007/s11060-011-0701-7. Epub 2011 Sep 18.

PMID:
21928115
18.

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.

Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16.

PMID:
21790828
19.

5q12.1 deletion: delineation of a phenotype including mental retardation and ocular defects.

Jaillard S, Andrieux J, Plessis G, Krepischi AC, Lucas J, David V, Le Brun M, Bertola DR, David A, Belaud-Rotureau MA, Mosser J, Lazaro L, Treguier C, Rosenberg C, Odent S, Dubourg C.

Am J Med Genet A. 2011 Apr;155A(4):725-31. doi: 10.1002/ajmg.a.33758. Epub 2011 Mar 15.

PMID:
21594994
20.

Mechanisms of immunomodulation in human glioblastoma.

Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V.

Immunotherapy. 2011 Apr;3(4 Suppl):42-4. doi: 10.2217/imt.11.39. Review.

PMID:
21524170
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk